Version 1
: Received: 17 June 2024 / Approved: 18 June 2024 / Online: 18 June 2024 (08:16:27 CEST)
How to cite:
Rusiñol, L.; Puig, L. Review of the Il-18 and IL37 Implications in the Pathogenesis of Atopic Dermatitis and Psoriasis: Prospective Treatment Targets. Preprints2024, 2024061196. https://doi.org/10.20944/preprints202406.1196.v1
Rusiñol, L.; Puig, L. Review of the Il-18 and IL37 Implications in the Pathogenesis of Atopic Dermatitis and Psoriasis: Prospective Treatment Targets. Preprints 2024, 2024061196. https://doi.org/10.20944/preprints202406.1196.v1
Rusiñol, L.; Puig, L. Review of the Il-18 and IL37 Implications in the Pathogenesis of Atopic Dermatitis and Psoriasis: Prospective Treatment Targets. Preprints2024, 2024061196. https://doi.org/10.20944/preprints202406.1196.v1
APA Style
Rusiñol, L., & Puig, L. (2024). Review of the Il-18 and IL37 Implications in the Pathogenesis of Atopic Dermatitis and Psoriasis: Prospective Treatment Targets. Preprints. https://doi.org/10.20944/preprints202406.1196.v1
Chicago/Turabian Style
Rusiñol, L. and Lluís Puig. 2024 "Review of the Il-18 and IL37 Implications in the Pathogenesis of Atopic Dermatitis and Psoriasis: Prospective Treatment Targets" Preprints. https://doi.org/10.20944/preprints202406.1196.v1
Abstract
Atopic dermatitis and psoriasis are prevalent inflammatory skin conditions with diverse treatment options. Despite advances in understanding their underlying mechanisms, recent research highlights the significance of interleukins IL-18 and IL-37 as potential therapeutic targets. This review synthesizes knowledge on these interleukins, their roles in atopic dermatitis and psoriasis, and emerging treatment strategies. Findings of a literature search up to May 30, 2024 underscore a research gap in IL-37-targeted therapies. Conversely, IL-18-focused treatments have demonstrated promise in adult-onset Still’s Disease, warranting further exploration for their potential efficacy in psoriasis and atopic dermatitis.
Keywords
psoriasis; atopic dermatitis; IL-18; IL-37
Subject
Medicine and Pharmacology, Dermatology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.